To further explore the therapeutic potential of targeting the DLEU1/ASCC2/G6PD axis in GC, we established stable MKN45 cell lines transduced with shNC, shDLEU1, or shDLEU1 in combined with shASCC2 and subcutaneously implanted them into nude mice. This evidence concerns the gene ASCC2 and gastric cancer.